ArticleScientific reports2026
Validation of ferroptosis in zebrafish as a reliable model for phenotypic studies.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In recent years, ferroptosis has attracted considerable attention as a novel form of cell death. With the deepening of research into its mechanisms, ferroptosis has gained increasing significance. Currently, the vast majority of ferroptosis-related studies are conducted on mice; however, mouse breeding requires a relatively long time, and the cost of gene screening is high. In contrast, zebrafish, as a small-sized vertebrate model organism with a short growth cycle, shares 85% genetic homology with humans.Zebrafish larvae have transparent bodies, which allows for convenient and intuitive observation of their developmental status during the early developmental stage. Would conducting ferroptosis-related experiments on zebrafish larvae be more convenient and efficient than on mice? To verify this hypothesis, the present study treated zebrafish embryos with two ferroptosis inducers (Erastin, FIN56) and ammonium ferric citrate (FAC). The levels of reactive oxygen species (ROS), glutathione (GSH)/oxidized glutathione (GSSG) ratio, somatic cell death, and the expression levels of ferroptosis-related genes and proteins were detected, and differentiated from apoptotic and autophagic indicators. Additionally, ferroptosis-induced impairment of vascular development was observed in transgenic zebrafish with vascular-specific fluorescence. The results of this study indicate that: A ferroptosis model can be successfully established in zebrafish; Ferroptosis significantly inhibits angiogenesis in zebrafish. These findings lay a foundation for future ferroptosis-related research using zebrafish.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.